CDC panel recommends resuming use of Johnson & Johnson COVID-19 vaccine

A CDC panel voted Friday to recommend resuming use of Johnson & Johnson's Janssen vaccine to protect against COVID-19, two weeks after the single-dose shot was placed on pause over blood clot concerns. Here's what you need to know.

CDC panel recommends resuming use of Johnson & Johnson COVID-19 vaccine

Photo: ic-cdn.flipboard.com